Collectively, these results suggest that BsTE:T exhibits anti-tumor activity in a PD-L1-dependent manner through enhanced T-cell trafficking into the tumor, which is influenced by PD-L1+ exosomes. The gene discussed is CD274; the disease is neoplasm.